PDF(Pubmed)
Abstract：
UNASSIGNED: 16-66% of COVID-19 positive patients may have abdominal symptoms and findings in abdominal CT. The yield of abdominal CT scan in patients having abdominal complaints is not known.
UNASSIGNED: The aim of this study was to explore the various abdominal imaging manifestations of COVID-19 and COVID-19 associated Mucormycosis (CAM) and to identify the relevant clinical and laboratory features associated with severity of the symptoms.
UNASSIGNED: A retrospective single centre observational study was performed at a tertiary care hospital in Northwest India. All consecutive patients who had COVID positive RT-PCR report and had undergone abdominal Computed Tomography scan from March 2020 to November 2021 for various abdominal complaints were included. Demographic data, CT images and reports and all relevant lab parameters were collected.
UNASSIGNED: Out of 75 patients, positive abdominal findings were seen in 65 patients. Hepatobiliary findings were seen in 41.3% (31 of 75; OR=1.9) and bowel abnormalities were found in 37.3% (28 of 75; OR=2.1) of COVID-19 patients. 7 patients who had renal infarcts or bowel ischemia were found to have COVID-19 associated Mucormycosis on histopathology.
UNASSIGNED: Chest CT severity score was positively correlated with most of the abdominal manifestations in patients requiring ICU admission. Elevated D-dimer levels were significantly associated with abdominal symptoms.
UNASSIGNED: The aim of this study was to explore the various abdominal imaging manifestations of COVID-19 and COVID-19 associated Mucormycosis (CAM) and to identify the relevant clinical and laboratory features associated with severity of the symptoms.
UNASSIGNED: A retrospective single centre observational study was performed at a tertiary care hospital in Northwest India. All consecutive patients who had COVID positive RT-PCR report and had undergone abdominal Computed Tomography scan from March 2020 to November 2021 for various abdominal complaints were included. Demographic data, CT images and reports and all relevant lab parameters were collected.
UNASSIGNED: Out of 75 patients, positive abdominal findings were seen in 65 patients. Hepatobiliary findings were seen in 41.3% (31 of 75; OR=1.9) and bowel abnormalities were found in 37.3% (28 of 75; OR=2.1) of COVID-19 patients. 7 patients who had renal infarcts or bowel ischemia were found to have COVID-19 associated Mucormycosis on histopathology.
UNASSIGNED: Chest CT severity score was positively correlated with most of the abdominal manifestations in patients requiring ICU admission. Elevated D-dimer levels were significantly associated with abdominal symptoms.
摘要：
■16-66%的COVID-19阳性患者可能有腹部症状和腹部CT表现。腹部不适患者的腹部CT扫描结果尚不清楚。
本研究的目的是探讨COVID-19和COVID-19相关毛霉菌病（CAM）的各种腹部影像学表现，并确定与症状严重程度相关的相关临床和实验室特征。
■在印度西北部的一家三级保健医院进行了一项回顾性单中心观察性研究。纳入了所有连续的患者，这些患者在2020年3月至2021年11月期间接受了各种腹部不适的腹部计算机断层扫描。人口统计数据,收集CT图像和报告以及所有相关实验室参数。
■在75名患者中，65例患者的腹部检查结果呈阳性.在COVID-19患者中，有41.3%(75例中的31例；OR=1.9)的肝胆表现，有37.3%(75例中的28例；OR=2.1)的肠异常。在组织病理学上发现7例患有肾梗塞或肠缺血的患者患有COVID-19相关的毛霉菌病。
■需要入住ICU的患者，胸部CT严重程度评分与大多数腹部表现呈正相关。D-二聚体水平升高与腹部症状显著相关。
本研究的目的是探讨COVID-19和COVID-19相关毛霉菌病（CAM）的各种腹部影像学表现，并确定与症状严重程度相关的相关临床和实验室特征。
■在印度西北部的一家三级保健医院进行了一项回顾性单中心观察性研究。纳入了所有连续的患者，这些患者在2020年3月至2021年11月期间接受了各种腹部不适的腹部计算机断层扫描。人口统计数据,收集CT图像和报告以及所有相关实验室参数。
■在75名患者中，65例患者的腹部检查结果呈阳性.在COVID-19患者中，有41.3%(75例中的31例；OR=1.9)的肝胆表现，有37.3%(75例中的28例；OR=2.1)的肠异常。在组织病理学上发现7例患有肾梗塞或肠缺血的患者患有COVID-19相关的毛霉菌病。
■需要入住ICU的患者，胸部CT严重程度评分与大多数腹部表现呈正相关。D-二聚体水平升高与腹部症状显著相关。
